No profile data available.
Celcuity Inc. (CELC) is a healthcare company in the breast cancer treatment drugs industry, based in Minneapolis, United States, with about 155 full-time employees.
It reported revenue of $0 for fiscal year 2025, and net income of -$177.04 million. In Q2 2026 (the quarter ended June 30, 2026) revenue was $0. Its market capitalization was $3.32 billion as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2025; market data as of October 9, 2026.
, a clinical-stage biotechnology company, focuses on the development of targeted therapies for the treatment of various solid tumors in the United States.
Celcuity reported $0 in revenue for fiscal year 2025. In Q2 2026 revenue was $0.
$3.32 billion as of October 9, 2026.
Listed companies of a similar size in the same industry (breast cancer treatment drugs) include Olema Pharmaceuticals, Inc. (OLMA), Puma Biotechnology, Inc. (PBYI), Greenwich LifeSciences, Inc. (GLSI), Odonate, Inc. (ODTC).